UK Markets close in 7 hrs 56 mins

Bonesupport Holding AB (publ) (0RQO.L)

LSE - LSE Delayed price. Currency in SEK
Add to watchlist
75.27+2.07 (+2.83%)
As of 05:44PM BST. Market open.

Bonesupport Holding AB (publ)

Scheelevägen 19
Lund 223 70
Sweden
46 4 62 86 53 70
https://www.bonesupport.com

Sector(s)
Industry
Full-time employees87

Key executives

NameTitlePayExercisedYear born
Mr. Emil BillbäckChief Exec. Officer9.91MN/A1970
Prof. Lars A. Lidgren M.D., Ph.D.Founder & Director161kN/A1943
Mr. Håkan JohanssonChief Financial OfficerN/AN/A1963
Ms. Annelie Aava ViknerExec. VP of Marketing & CommunicationsN/AN/A1971
Ms. Helena L. BrandtHead of HRN/AN/A1965
Dr. Michael Diefenbeck M.D., Ph.D.Exec. VP of Medical & Clinical Affairs and Chief Medical OfficerN/AN/A1974
Dr. Jerry ChangExec. VP of R&D, Regulatory and ClinicalN/AN/A1959
Mr. Fergus MacLeodGM & Exec. VP of Commercial Operations of EUROWN/AN/A1970
Ms. Kristina IngvarExec. VP of Quality Management & Regulatory AffairsN/AN/A1972
Mr. Michael RothGM & Exec. VP of Commercial Operations of North AmericaN/AN/A1963
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.

Description

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bioceramic bone graft substitutes for the treatment of bone voids in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable, moldable, and drillable synthetic bone void filler that includes hydroxyapatite, calcium sulfate, and the radio-contrast agent iohexol; CERAMENT G, a gentamicin injectable ceramic bone graft substitute; and CERAMENT V, a vancomycin injectable synthetic bone void filler. It also develops preclinical product candidates to promote bone regrowth focusing on trauma, revision arthroplasty, chronic osteomyelitis, revision artroplasty, and oncology, as well as bone and foot infections due to diabetes. The company was founded in 1999 and is headquartered in Lund, Sweden.

Corporate governance

Bonesupport Holding AB (publ)’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.